🇺🇸 FDA
Pipeline program

Humalog

HALO-117-204

Phase 2 small_molecule completed

Quick answer

Humalog for Diabetes Mellitus, Type 2 is a Phase 2 program (small_molecule) at HALOZYME THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
HALOZYME THERAPEUTICS, INC.
Indication
Diabetes Mellitus, Type 2
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials